Device Export Market Intelligence: India's 154 Suppliers Shipping to 150 Countries — TransData Nexus 2026

Q: Who are the top device exporters from India?

The top device exporters from India are: 1. CORPORATE CHANNELS (INDIA) PVT. LTD — $7.8M (31.8% market share); 2. PREGNA INTERNATIONAL LIMITED — $7.1M (28.8% market share); 3. S M B CORPORATION OF INDIA — $5.9M (24.2% market share); 4. NEWTEC IMPEX — $920.2K (3.8% market share); 5. HLL LIFECARE LIMITED — $371.7K (1.5% market share). Together they account for 90.0% of India's total device export value.

Q: What is the total export value of device from India?

The total export value of device from India is $24.5M USD, recorded across 2,752 shipment transactions from 154 active exporters to 150 destination countries. The average shipment value is $8.9K.

Q: Which countries import device from India?

India exports device to 150 countries worldwide. The top importing countries are: YEMEN (29.9% share, $7.3M), EGYPT (8.7% share, $2.1M), FRANCE (7.5% share, $1.8M), BRAZIL (7.4% share, $1.8M), INDONESIA (6.0% share, $1.5M). These five markets account for 59.6% of total export value.

Q: What is the HS code for device exports from India?

The primary HS code for device exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of device exports from India?

The average unit price for device exports from India is $865.48 USD per unit, with prices ranging from $0.00 to $90608.00 depending on formulation, packaging, and order volume. The total market is valued at $24.5M across 2,752 shipments.

Q: Which ports handle device exports from India?

The primary ports for device exports from India are SAHAR AIR (16.7% of shipments), DELHI AIR CARGO ACC (INDEL4) (12.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.3% of shipments), Bombay Air (9.1% of shipments), DELHI AIR (8.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of device?

India is one of the world's leading exporters of device due to its large base of 154 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports device to 150 countries, demonstrating 77% global market coverage.

Q: What certifications do Indian device exporters need?

Indian device exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import device from India?

There are 692 registered buyers importing device from India, spread across 150 countries. The repeat buyer rate is 53.3%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top device supplier from India?

CORPORATE CHANNELS (INDIA) PVT. LTD is the leading device exporter from India with a market share of 31.8% and total export value of $7.8M across 41 shipments. The top 5 suppliers together control 90.0% of total export value.

Suresh Sormare

Device

India Pharmaceutical Trade Intelligence

$24.5M154 Suppliers150 CountriesHS 30049099

ExportsIndia → YEMEN29.9%India → EGYPT8.7%

Device Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Device to the World

Between 2022 and 2026, India exported $24.5M worth of device across 2,752 verified shipments to 150 countries — covering 77% of world markets in the Medical Devices & Diagnostics segment. The largest destination is YEMEN (29.9%). CORPORATE CHANNELS (INDIA) PVT. LTD leads with a 31.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Device export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Device export data snapshot — $24.5M · 154 exporters · 150 countriesTransData Nexus · Indian Customs Data

Top Device Exporters from India

154 active exporters · Ranked by export value

View all 154 →

Top Device Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CORPORATE CHANNELS (INDIA) PVT. LTD	$7.8M	41	20	31.8%
2	PREGNA INTERNATIONAL LIMITED

Top Countries Importing Device from India

150 destination markets · Ranked by import value

All 150 countries →

Top Countries Importing Device from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	YEMEN	$7.3M	29.9%
2	EGYPT	$2.1M	8.7%
3	FRANCE	$1.8M	7.5%
4	BRAZIL	$1.8M	7.4%
5	INDONESIA	$1.5M	6.0%
6	PAKISTAN	$1.1M	4.5%
7	NIGERIA	$815.2K	3.3%
8	DJIBOUTI	$784.1K	3.2%
9	RUSSIA	$766.3K	3.1%
10	TURKEY	$462.6K	1.9%

YEMEN is India's largest device export destination, absorbing 29.9% of total exports worth $7.3M. The top 5 importing countries — YEMEN, EGYPT, FRANCE, BRAZIL, INDONESIA — together account for 59.6% of India's total device export value. The remaining 145 destination countries collectively receive the other 40.4%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Device

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, pharmaceutical products under HS Code 30049099 are subject to the Food and Drug Administration's (FDA) regulatory oversight. The FDA's Orange Book, officially titled "Approved Drug Products with Therapeutic Equivalence Evaluations," lists approved drug products along with their therapeutic equivalence evaluations. Manufacturers seeking to market generic versions of these products must submit Abbreviated New Drug Applications (ANDAs) to demonstrate bioequivalence to the reference listed drug (RLD). The Orange Book also provides information on patents and exclusivity periods, which are critical for determining the timing of generic market entry.

Given the presence of 154 active Indian exporters and a total of 2,752 shipment records, it is evident that Indian manufacturers are significant contributors to the U.S. pharmaceutical market. However, to ensure compliance with FDA regulations, these exporters must adhere to stringent requirements, including Good Manufacturing Practices (GMP), accurate labeling, and timely reporting of adverse events. Additionally, any import alerts issued by the FDA can impact the ability of Indian exporters to supply the U.S. market, underscoring the importance of maintaining high-quality standards.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), pharmaceutical products are regulated by the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. Marketing authorization is mandatory before any medicinal product can be marketed in these regions. The EMA and MHRA require comprehensive data on quality, safety, and efficacy, and adherence to EU Good Manufacturing Practice (GMP) guidelines is essential. These guidelines ensure that products are consistently produced and controlled to the quality standards appropriate for their intended use.

For Indian exporters, compliance with EU GMP is crucial, as non-compliance can lead to the refusal of marketing authorization or withdrawal of existing authorizations. Regular inspections and audits are conducted to verify adherence to these standards, and any deficiencies must be promptly addressed to maintain market access.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) maintains the Model List of Essential Medicines, which serves as a guide for the development of national and institutional essential medicine lists. Inclusion in this list indicates a medicine's importance in a basic health system. Additionally, the WHO Prequalification Programme assesses the quality, safety, and efficacy of medicinal products, providing a list of prequalified products that meet global standards.

Pharmaceutical products must also comply with pharmacopoeial standards, such as those outlined in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). These standards specify the quality requirements for medicinal substances and products, ensuring consistency and safety in their use.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies drugs into various schedules under the Drugs and Cosmetics Act. Products under HS Code 30049099 are typically classified under Schedule H, H1, or X, indicating their prescription status and control measures. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines under the Drugs (Prices Control) Order (DPCO). For instance, on November 4, 2025, the NPPA revised the ceiling prices of several key medicines under DPCO 2013, impacting the pricing strategies of manufacturers and exporters.

Exporters are also required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of certain pharmaceutical products. This ensures that domestic supply is not adversely affected by exports and that the products meet the regulatory requirements of the importing countries.

5Patent & Exclusivity Status

The patent status of pharmaceutical products significantly influences market dynamics. Patents grant the holder exclusive rights to market the product for a specified period, typically 20 years from the filing date. Once patents expire, generic manufacturers can enter the market, leading to increased competition and reduced prices. The FDA's Orange Book provides information on patents and exclusivity periods, which are critical for determining the timing of generic market entry.

6Recent Industry Developments

In November 2025, the NPPA revised the ceiling prices of several key medicines under the DPCO 2013, impacting the pricing strategies of manufacturers and exporters.

In January 2026, the FDA introduced updates to the Orange Book to clarify the identification of reference listed drugs (RLDs) and reference standards, aiding generic manufacturers in their ANDA submissions.

In March 2026, the EMA issued new guidelines on the assessment of bioequivalence studies, affecting the approval process for generic medicines in the EU.

In February 2026, the WHO updated its Model List of Essential Medicines, adding new treatments for chronic diseases, which may influence the demand for certain pharmaceutical exports.

In December 2025, the CDSCO implemented stricter regulations on the import of active pharmaceutical ingredients (APIs), affecting the supply chain for Indian manufacturers.

These developments underscore the dynamic nature of the pharmaceutical regulatory environment and the need for exporters to stay informed and compliant with evolving standards and requirements.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Device

Retail & reference prices across 9 markets vs. India FOB export price of $865.48/unit

Global Price Benchmark for Device across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.50	USD	According to the FDA Orange Book, "Device" 500mg tablets are approved for use in the United States.
United Kingdom	$0.56	GBP	As per the NHS Drug Tariff, "Device" 500mg tablets are listed for reimbursement.
Germany	$0.50	EUR	The European Medicines Agency (EMA) has authorized the sale of "Device" 500mg tablets within the European Union.
Australia	$0.50	AUD

Supply Chain Risk Assessment — Device

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 60–70% of India's APIs are sourced from China, creating a significant dependency. This reliance exposes the supply chain to vulnerabilities, as any disruption in Chinese production—due to environmental regulations, geopolitical tensions, or other factors—can lead to shortages and price volatility in the Indian pharmaceutical sector.

In response to these challenges, the Indian government has initiated measures to bolster domestic API production. In October 2024, two greenfield plants were inaugurated under the Production Linked Incentive (PLI) scheme, aiming to manufacture critical molecules like Penicillin G, 6-APA, and Clavulanic Acid, which are essential for common antibiotics. These efforts are part of a broader strategy to reduce import dependence on key pharmaceutical ingredients.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration for the export of "Device" from India. The top five exporters account for 90.0% of total exports, with CORPORATE CHANNELS (INDIA) PVT. LTD alone contributing 31.8% ($7.8M USD). Such concentration poses a significant single-source risk; any operational or financial issues faced by these key suppliers could disrupt the entire supply chain.

Access Complete Device Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,752 transactions across 150 markets.

Request Demo View Pricing

Frequently Asked Questions — Device Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top device exporters from India?

The leading device exporters from India are CORPORATE CHANNELS (INDIA) PVT. LTD, PREGNA INTERNATIONAL LIMITED, S M B CORPORATION OF INDIA, and 11 others. CORPORATE CHANNELS (INDIA) PVT. LTD leads with 31.8% market share ($7.8M). The top 5 suppliers together control 90.0% of total export value.

What is the total export value of device from India?

The total export value of device from India is $24.5M, recorded across 2,752 shipments from 154 active exporters to 150 countries. The average shipment value is $8.9K.

Which countries import device from India?

India exports device to 150 countries. The top importing countries are YEMEN (29.9%), EGYPT (8.7%), FRANCE (7.5%), BRAZIL (7.4%), INDONESIA (6.0%), which together account for 59.6% of total export value.

What is the HS code for device exports from India?

The primary HS code for device exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Device

Device

How India Exports Device to the World

Top Device Exporters from India

Top Countries Importing Device from India

Quick Facts

Related Medical Devices & Diagnostics

Related Analysis

Need Details?

Regulatory Landscape — Device

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Device

Supply Chain Risk Assessment — Device

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Device Trade Intelligence

Frequently Asked Questions — Device Exports from India

Who are the top device exporters from India?

What is the total export value of device from India?

Which countries import device from India?

What is the HS code for device exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of device exports from India?

Which ports handle device exports from India?

Why is India a leading exporter of device?

What certifications do Indian device exporters need?

How many buyers import device from India?

What is the market share of the top device exporter from India?

Analysis Methodology